BIOMAT Database Logo BIOMAT Database Logo

Hormone and cytokine circadian alteration in non-small cell lung cancer patients. 2012

G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Department of Medical Sciences,IRCCS Scientific Institute and Regional General Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. g.mazzoccoli@operapadrepio.it

Alterations in hormone secretion and cytokine levels have been evidenced in many neoplastic diseases. In this study we have evaluated the circadian profile of growth hormone (GH), insulin-like growth factor-1 (IGF-1), interleukin-2 (IL2), melatonin (MEL) and cortisol (COR) serum levels in non-small cell lung cancer patients. Blood was sampled every 4 h for 24 h in 11 healthy (H) men (ages 35-53 years) and 9 men with stage 2, 3 or 4 non-small cell lung cancer (C) (ages 43-63 years). Serum GH, total IGF1, IL2, MEL and COR were measured and examined for group differences, trends, and rhythm characteristics. 24-h means were significantly higher in C234 vs H for GH, GH/IGF1, IL2 and COR, and lower for IGF1, but IL2 and COR were not different for C23 vs H. A linear regression across 4 groups (H, C2, C3, C4) found a positive trend for COR, GH, GH/IGF1 and IL2, and a negative trend for IGF1. A linear regression run between the 24-h mean levels of GH, IGF1, COR, MEL and IL2 in healthy subjects evidenced a statistically significant positive trend between MEL and GH (R = 0.281, p = 0.022) and in cancer patients showed a statistically significant negative trend between GH and IGF1 (R = 0.332, p = 0.01), COR and IGF1 (R=0.430, p=0.001), and a statistically significant positive trend between the 24-h mean of COR and GH (R = 0.304, p = 0.02). Rhythms in MEL and COR (peaks near 01:00h and 08:00h, respectively) indicated identical synchronization to the light-dark cycle for both groups. A circadian rhythm was detected in GH and GH/IGF1 for C23 and H, with IGF1 and IL2 non-rhythmic in any group. In conclusion, an increasing trend and progressive loss of circadian rhythmicity in GH and GH/IGF1, an increasing trend in cortisol and IL2, and a decreasing trend in IGF1 in C, reflect a complex chain of events that could be involved in progression of neoplastic disease. A therapeutic strategy needs to take into account circadian patterns and complex interactions of the multiple functions that characterize the hormone and cytokine levels in the frame cancer progression.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone

Related Publications

G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Circadian function in patients with advanced non-small-cell lung cancer.
November 2005, British journal of cancer,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Cytokine immunotherapy of non-small cell lung cancer.
January 1993, Regional immunology,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer.
November 2000, Lung cancer (Amsterdam, Netherlands),
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer.
September 2009, Advances in therapy,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
[Progress of BRAF Gene Alteration in Non-small Cell Lung Cancer].
January 2024, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Salivary cytokine panel indicative of non-small cell lung cancer.
September 2018, The Journal of international medical research,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Prognostic significance of cytokine modulation in non-small cell lung cancer.
September 2002, International journal of cancer,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients.
May 2018, Cellular and molecular biology (Noisy-le-Grand, France),
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.
December 2017, Pharmacogenetics and genomics,
G Mazzoccoli, and R B Sothern, and M Francavilla, and F Giuliani, and S Carughi, and L A Muscarella, and V M Fazio, and P Parrella, and M Vinciguerra, and R Tarquini
Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancer.
December 2001, Lung cancer (Amsterdam, Netherlands),
Copied contents to your clipboard!